Endothelin-1 does not contribute to the release of tissue plasminogen activator in vivo in man
1999
Objectives: Endothelin-1 is a potent endothelium-derived vasoconstrictor peptide with autocrine and paracrine actions. Tissue plasminogen activator (t-PA) and its inhibitor, plasminogen activator inhibitor type 1 (PAI-1), are also released from the vascular endothelium and play a pivotal role in endogenous fibrinolysis. We, therefore, examined the effects of exogenous and endogenous endothelin-1 on t-PA and PAI-1 release in vivo in man.
Design: Open investigative study.
Setting: Clinical Research Centre, University of Edinburgh.
Subjects: Fourteen healthy male volunteers.
Interventions: Unilateral brachial artery infusions of endothelin-1 at 2.5 and 10 pmol/min, and the selective endothelin type B (ETB) receptor antagonist, BQ-788, at 1 nmol/min.
Main outcome measures: Blood, flow and plasma fibrinolytic factors were measured in both forearms using venous occlusion plethysmography and venous blood samples withdrawn from the antecubital fossae.
Results: Endothelin-1 caused a slow onset dose-dependent forearm vasoconstriction (P<0.001) with a maximal reduction in blood flow of 40 ± 4% and 63 ± 3% at 2.5 and 10 pmol/min respectively. BQ-788 also caused a slow onset reduction in forearm blood flow (P<0.001) reaching a maximum of 21 ± 3%. However, BQ-788 and endothelin-1 did not affect plasma concentrations of t-PA or PAI-1 in the venous effluent of the infused forearm.
Conclusions: Despite sustaining significant vasoconstriction, neither endogenous nor exogenous endothelin-1 influences the release of t-PA or PAI-1 in the forearm vascular bed of man. This suggests that endothelin-1 does not provide a major contribution to the regulation of endogenous fibrinolysis in man.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
31
References
1
Citations
NaN
KQI